# Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)

> **NCT01477528** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 201 (actual)

## Conditions studied

- Anticoagulation
- Left Ventricular Assist Device

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01477528
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-07
- **Final completion:** 2015-08
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2022-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477528, "Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01477528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*